Evasion and subversion of antigen presentation by Mycobacterium tuberculosis

被引:118
作者
Baena, A. [1 ]
Porcelli, S. A. [1 ,2 ]
机构
[1] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA
[2] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA
来源
TISSUE ANTIGENS | 2009年 / 74卷 / 03期
基金
美国国家卫生研究院;
关键词
antigen presentation; CD1; immune evasion; major histocompatibility complex class II; major histocompatibility complex class I; Mycobacterium tuberculosis; vaccine; MHC-CLASS-II; T-CELL RESPONSES; BACILLUS-CALMETTE-GUERIN; DENDRITIC CELLS; 19-KDA LIPOPROTEIN; HUMAN MACROPHAGES; BOVIS BCG; CROSS-PRESENTATION; IFN-GAMMA; CATHEPSIN-S;
D O I
10.1111/j.1399-0039.2009.01301.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Mycobacterium tuberculosis is one of the most successful of human pathogens and has acquired the ability to establish latent or progressive infection and persist even in the presence of a fully functioning immune system. The ability of M. tuberculosis to avoid immune-mediated clearance is likely to reflect a highly evolved and coordinated program of immune evasion strategies, including some that interfere with antigen presentation to prevent or alter the quality of T-cell responses. Here, we review an extensive array of published studies supporting the view that antigen presentation pathways are targeted at many points by pathogenic mycobacteria. These studies show the multiple potential mechanisms by which M. tuberculosis may actively inhibit, subvert or otherwise modulate antigen presentation by major histocompatibility complex class I, class II and CD1 molecules. Unraveling the mechanisms by which M. tuberculosis evades or modulates antigen presentation is of critical importance for the development of more effective new vaccines based on live attenuated mycobacterial strains.
引用
收藏
页码:189 / 204
页数:16
相关论文
共 143 条
  • [1] Mycobacterium tuberculosis malate synthase- and MPT51-based serodiagnostic assay as an adjunct to rapid identification of pulmonary tuberculosis
    Achkar, Jacqueline M.
    Dong, Yuxin
    Holzman, Robert S.
    Belisle, John
    Kourbeti, Irene S.
    Sherpa, Tsering
    Condos, Rany
    Rom, William N.
    Laal, Suman
    [J]. CLINICAL AND VACCINE IMMUNOLOGY, 2006, 13 (11) : 1291 - 1293
  • [2] Protective immunity to tuberculosis with Ag85B-ESAT-6 in a synthetic cationic adjuvant system IC31
    Agger, Else Marie
    Rosenkrands, Ida
    Olsen, Anja Weinreich
    Hatch, Graham
    Williams, Ann
    Kritsch, Constantia
    Lingnau, Karen
    von Gabain, Alexander
    Andersen, Claire Swetman
    Korsholm, Karen Smith
    Andersen, Peter
    [J]. VACCINE, 2006, 24 (26) : 5452 - 5460
  • [3] [Anonymous], 2008, Global tuberculosis control - surveillance, planning, financing
  • [4] Pathogen evasion strategies for the major histocompatibility complex class I assembly pathway
    Antoniou, Antony N.
    Powis, Simon J.
    [J]. IMMUNOLOGY, 2008, 124 (01) : 1 - 12
  • [5] Potent inhibition of macrophage responses to IFN-γ by live virulent Mycobacterium tuberculosis is independent of mature mycobacterial lipoproteins but dependent on TLR2
    Banaiee, Niaz
    Kincaid, Eleanor Z.
    Buchwald, Ulrike
    Jacobs, William R., Jr.
    Ernst, Joel D.
    [J]. JOURNAL OF IMMUNOLOGY, 2006, 176 (05) : 3019 - 3027
  • [6] CD1 antigen presentation: how it works
    Barral, Duarte C.
    Brenner, Michael B.
    [J]. NATURE REVIEWS IMMUNOLOGY, 2007, 7 (12) : 929 - 941
  • [7] Innate immune functions of human γδ T cells
    Beetz, Susann
    Wesch, Daniela
    Marischen, Lothar
    Welte, Stefan
    Oberg, Hans-Heinrich
    Kabelitz, Dieter
    [J]. IMMUNOBIOLOGY, 2008, 213 (3-4) : 173 - 182
  • [8] Susceptibility of mice deficient in CD1D or TAP1 to infection with Mycobacterium tuberculosis
    Behar, SM
    Dascher, CC
    Grusby, MJ
    Wang, CR
    Brenner, MB
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (12) : 1973 - 1980
  • [9] Blythe Martin J, 2007, Immunome Res, V3, P10, DOI 10.1186/1745-7580-3-10
  • [10] Identification and characterization of protective T cells in hsp65 DNA-vaccinated and Mycobacterium tuberculosis-infected mice
    Bonato, VLD
    Lima, VMF
    Tascon, RE
    Lowrie, DB
    Silva, CL
    [J]. INFECTION AND IMMUNITY, 1998, 66 (01) : 169 - 175